Table 1.
Synergetic activity of rifampicin and vancomycin with tridecaptin M against Gram-negative bacteria.
| Strain | Tri-M MIC (µg/mL) | Antibiotic | Tri-M Concentration (µg/mL) |
MIC (µg/mL) | Potentiation Factor | FICI |
|---|---|---|---|---|---|---|
|
A. baumannii
ATCC 19606 |
32 | Vancomycin | 0 | 128 | ||
| 2 | 128 | 1 | - | |||
| 4 | 32 | 4 | 0.375 | |||
| 8 | 8 | 16 | 0.312 | |||
| Rifampicin | 0 | 4 | ||||
| 2 | 2 | 2 | 0.562 | |||
| 4 | 1 | 4 | 0.375 | |||
| 8 | 0.25 | 16 | 0.312 | |||
|
K. pneumoniae
ATCC 700603 |
4 | Vancomycin | 0 | 128 | ||
| 0.25 | 128 | 1 | - | |||
| 0.5 | 128 | 1 | - | |||
| 1.0 | 128 | 1 | - | |||
| Rifampicin | 0 | 32 | ||||
| 0.25 | 32 | 1 | - | |||
| 0.5 | 32 | 1 | - | |||
| 1.0 | 32 | 1 | - | |||
|
P. aeruginosa
ATCC 27853 |
256 | Vancomycin | 0 | 256 | ||
| 4 | 256 | 1 | - | |||
| 8 | 256 | 1 | - | |||
| 16 | 256 | 1 | - | |||
| Rifampicin | 0 | 64 | ||||
| 4 | 32 | 2 | 0.515 | |||
| 8 | 32 | 2 | 0.531 | |||
| 16 | 32 | 2 | 0.562 |
Tri-M—tridecaptin M; FICI—fractional inhibitory concentration index. FICI of ≤0.5 was considered as synergy. (-) represents no change in MIC, and hence, FICI was not calculated for these.